A significant new UAB study published in Cancer shows that key socioeconomic factors, not race, affect survival of younger multiple myeloma patients.
UAB now offers the largest cancer precision medicine clinical trial, NCI-MATCH, with customized treatments for patients based on genetics.
A workshop is set to provide information and resources for MDS patients and families June 25.
The renowned Association of American Physicians has selected four UAB physicians for induction.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
Karim Budhwani, a materials science and engineering (MSE) and biomedical engineering (BME) graduate student, presented to the Alabama Commission for Higher Education (ACHE) on December 4, 2015 in Montgomery, Ala.
The Nov. 10 workshop will provide information and resources for lung cancer patients.
Wrong shipment of mice led to estrogen breakthrough in trauma survival.
A drug derived from female hormones that may help soldiers survive major blood loss on a battlefield will undergo first human testing at UAB.
UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.